The Discounted Cash Flow (DCF) valuation of Getein Biotech Inc (603387.SS) is 5.37 CNY. With the latest stock price at 8.19 CNY, the upside of Getein Biotech Inc based on DCF is -34.4%.
Based on the latest price of 8.19 CNY and our DCF valuation, Getein Biotech Inc (603387.SS) is a sell. selling 603387.SS stocks now will result in a potential gain of 34.4%.
| Range | Selected | |
| WACC / Discount Rate | 9.2% - 12.0% | 10.6% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 4.02 - 8.08 | 5.37 |
| Upside | -50.9% - -1.3% | -34.4% |